Cargando…
Advances in high‐throughput mass spectrometry in drug discovery
High‐throughput (HT) screening drug discovery, during which thousands or millions of compounds are screened, remains the key methodology for identifying active chemical matter in early drug discovery pipelines. Recent technological developments in mass spectrometry (MS) and automation have revolutio...
Autores principales: | Dueñas, Maria Emilia, Peltier‐Heap, Rachel E, Leveridge, Melanie, Annan, Roland S, Büttner, Frank H, Trost, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832828/ https://www.ncbi.nlm.nih.gov/pubmed/36515561 http://dx.doi.org/10.15252/emmm.202114850 |
Ejemplares similares
-
High-Throughput Native Mass Spectrometry Screening in Drug Discovery
por: Gavriilidou, Agni F. M., et al.
Publicado: (2022) -
Advances in Ultrahigh
Throughput Hit Discovery with
Tandem Mass Spectrometry Encoded Libraries
por: Mata, J. Miguel, et al.
Publicado: (2023) -
Advances in mass spectrometry-based clinical biomarker discovery
por: Crutchfield, Christopher A., et al.
Publicado: (2016) -
Native Mass Spectrometry in Fragment-Based Drug Discovery
por: Pedro, Liliana, et al.
Publicado: (2016) -
Proteomics characterisation of the L929 cell supernatant and its role in BMDM differentiation
por: Heap, Rachel E, et al.
Publicado: (2021)